Gray Nancy Ryan

Director at LGND

Sold, on record
$1.4M
Dollars the filings state
Form 4 sales
2
Latest Nov 7, 2025
Form 144 notices
2
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • LGNDLIGAND PHARMACEUTICALS INCDirector

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 144 notice LGNDNotice
    Feb 28, 2024 2024

    Filed to sell 831 shares ($75k)

    Gray Nancy Ryan, Director

    No 10b5-1 planFirst sale on recordFiling

  2. 2 Form 144 notice LGNDNotice
    May 9, 2024 +71 days

    Filed to sell 934 shares ($78k)

    Gray Nancy Ryan, Director

    No 10b5-1 planFirst sale on recordFiling

  3. 3 Form 4 sale LGNDNo plan
    May 9, 2024 same day

    Sold 934 shares at $83.20 ($78k)

    Gray Nancy Ryan, Director

    No 10b5-1 planSold 14.2% of holdings ($546k position)5,633 shares leftFirst sale on recordFollows a Form 144Filing

  4. 4 Form 4 sale LGNDUnusual
    Nov 7, 2025 +547 days

    Sold 6,571 shares at $205.45 ($1.4M)

    Gray Nancy Ryan, Director

    No 10b5-1 planSold 44.8% of holdings ($3M position)8,094 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Gray Nancy Ryan
Source
Nov 7, 2025Nov 12, 2025LGNDDirectorForm 4 sale6,571$1.4M44.8%UnusualSEC
May 9, 2024May 17, 2024LGNDDirectorForm 4 sale934$78k14.2%No planSEC
May 9, 2024May 9, 2024LGNDDirectorForm 144 notice934$78kNoticeSEC
Feb 28, 2024Feb 28, 2024LGNDDirectorForm 144 notice831$75kNoticeSEC